TY - JOUR
T1 - Update to the society of radiologists in ultrasound liver elastography consensus statement
AU - Barr, Richard G.
AU - Wilson, Stephanie R.
AU - Rubens, Deborah
AU - Garcia-Tsao, Guadalupe
AU - Ferraioli, Giovanna
PY - 2020/2
Y1 - 2020/2
N2 - This multidisciplinary update of the Society of Radiologists in Ultrasound consensus statement on liver elastography incorporates the large volume of new information available in the literature since the initial publication. The recommended procedure for acquiring stiffness measurements is reviewed. There has been substantial improvement in the acoustic radiation force impulse (ARFI) technology-most notably the addition of a quality assessment of the shear wave propagation. Due to the efforts of the Quantitative Imaging Biomarkers Alliance, or QIBA, the variability of liver stiffness measurements between systems had decreased. There are now effective treatments for hepatitis B and hepatitis C, and follow-up after effective treatment should be based on the use of the delta change of the value obtained at viral eradication or suppression. Because the detection of compensated advanced chronic liver disease (cACLD) is very important, the new guidelines are made based on the probability of cACLD for given stiffness values. The panel recommends a vendor-neutral rule of four for interpretation for ARFI techniques. This new method simplifies interpretation of liver stiffness results and is more clinically relevant.
AB - This multidisciplinary update of the Society of Radiologists in Ultrasound consensus statement on liver elastography incorporates the large volume of new information available in the literature since the initial publication. The recommended procedure for acquiring stiffness measurements is reviewed. There has been substantial improvement in the acoustic radiation force impulse (ARFI) technology-most notably the addition of a quality assessment of the shear wave propagation. Due to the efforts of the Quantitative Imaging Biomarkers Alliance, or QIBA, the variability of liver stiffness measurements between systems had decreased. There are now effective treatments for hepatitis B and hepatitis C, and follow-up after effective treatment should be based on the use of the delta change of the value obtained at viral eradication or suppression. Because the detection of compensated advanced chronic liver disease (cACLD) is very important, the new guidelines are made based on the probability of cACLD for given stiffness values. The panel recommends a vendor-neutral rule of four for interpretation for ARFI techniques. This new method simplifies interpretation of liver stiffness results and is more clinically relevant.
UR - http://www.scopus.com/inward/record.url?scp=85088496234&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088496234&partnerID=8YFLogxK
U2 - 10.1148/RADIOL.2020192437
DO - 10.1148/RADIOL.2020192437
M3 - Review article
C2 - 32515681
AN - SCOPUS:85088496234
VL - 296
SP - 263
EP - 274
JO - Radiology
JF - Radiology
SN - 0033-8419
IS - 2
ER -